The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Digital Pathology Global Market Report 2024, the digital pathology market is expected to show promising growth in the forecast period.

The digital pathology market has experienced significant growth in recent years, driven by various factors including technological advancements, increasing prevalence of diseases, and changing healthcare landscapes. This blog explores the key drivers, future projections, and major trends shaping the digital pathology market.

Market Overview and Growth Projections

Historic Growth Factors:

• Rapid Growth in Elderly Population: The aging population has led to a higher incidence of chronic diseases and cancer, necessitating advanced diagnostic tools.
• Increase in Medical Errors: The need to reduce errors in diagnosis has pushed the adoption of more reliable digital pathology solutions.
• Rising Cancer and Chronic Disease Rates: Growing prevalence of these conditions has fueled demand for accurate and timely diagnostics.
• Expansion of Healthcare Facilities and Expenditure: More healthcare facilities and increased spending have created a favorable environment for digital pathology.
• Public Health Insurance Reforms: Reforms have improved access to diagnostic services.
• Impact of COVID-19: The pandemic highlighted the need for efficient diagnostic technologies, boosting the market.

Current Market Size:

• The market grew from $1.07 billion in 2023 to $1.26 billion in 2024, reflecting a CAGR of 17.6%.

View More On The Digital Pathology Market Report 2024 – https://www.thebusinessresearchcompany.com/report/digital-pathology-global-market-report

Future Projections:

• Expected to grow to $2.41 billion by 2028, at a CAGR of 17.8%.
• Key Drivers:
  • Government Support: Policies and funding favoring digital health technologies.
  • Adoption of Digital Devices: Increased use of digital tools in healthcare.
  • Prevalence of Cancer and Chronic Diseases: Continues to drive demand for advanced diagnostics.
  • Aging Population: Persistent increase in elderly population.
  • Emergence of Infectious Diseases: New and recurring infections highlight the need for robust diagnostic solutions.

Trends Shaping the Future of Digital Pathology

Artificial Intelligence (AI):

• Improved Automation: AI enhances the automation of diagnostic processes, improving accuracy and efficiency.
• Image Classification: AI algorithms help in identifying disease features, such as cancer cells.
• Case Example: In January 2022, Inform Diagnostics launched the Paige FullFocus digital pathology viewer, leveraging AI for faster and more accurate diagnostics.

Cloud Technology:

• Standardization and Simplification: Cloud solutions streamline digital pathology deployments, making them more accessible and scalable.
• Data Security and Accessibility: Enhances the security of medical data and allows remote access for pathologists.

Digital Imaging and Video Streaming:

• Advanced Diagnostic Tools: These technologies improve the quality and speed of diagnostics.
• Enhanced Collaboration: Facilitates real-time consultation and collaboration among medical professionals.

Partnerships and R&D Investments:

• Expanding Product Portfolios: Companies are focusing on strategic partnerships to broaden their offerings.
• Innovation: Continuous investment in R&D to develop new technological solutions.

Cancer Prevalence Drives Market Demand

Impact of Rising Cancer Cases:

• Accelerated Diagnostics and Treatment: Digital pathology helps in quick and accurate cancer diagnosis.
• Increased Demand: The rise in cancer cases, partly due to an aging population and unhealthy lifestyles, drives market growth.

Statistics:

• According to the 2021 American Cancer Society report, 1.8 million new cancer cases were diagnosed in 2020.

Notable Company Activities

Mergers and Acquisitions:

• SourceBio International Plc Acquisition of LDPath Ltd.: In March 2022, SourceBio International acquired LDPath Ltd. for £18.5 million. This acquisition aims to strengthen SourceBio’s position in the digital pathology market, particularly in the UK, by providing advanced cellular pathology testing.

Key Players:

• Major Companies: Danaher Corporation, Hoffmann-La Roche Ltd., Koninklijke Philips N.V, Hamamatsu Photonics K.K, and others are driving innovation and expanding their market presence.

Market Segmentation

By Product:

• Scanners
• Software
• Storage and Communication Systems

By Type:

• Human Pathology
• Veterinary Pathology

By End-User:

• Pharmaceutical and Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic and Research Institutes

By Application:

• Drug Discovery
• Disease Diagnosis
• Teleconsultation
• Training and Education

Regional Insights

North America:

• Largest Market Region in 2023: High adoption rates of advanced technologies and well-established healthcare infrastructure.

Asia-Pacific:

• Rapid Growth Expected: Increasing healthcare investments and the growing burden of chronic diseases drive market expansion.

In conclusion, the digital pathology market is poised for substantial growth driven by technological advancements, increasing disease prevalence, and supportive government policies. The ongoing innovations and strategic activities by major players are set to further shape the future of this dynamic market.

Request A Sample Of The Global Digital Pathology Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=4107&type=smp